News

Hosted on MSN1y
Dr. Reddy’s Q4FY24 Results: Consumer Health segment to drive growth of India Business; To focus on M&A opportunities in FY25
Ramana, CEO, Branded Markets (India & Emerging Markets), Dr. Reddy’s Laboratories told Financial Express.com. He also said multiple aspects like Consumer Health ... are a good number of assets ...
Business Wire4mon
Dr. Reddy’s enters into collaboration with Henlius for commercialization of HLX15 (daratumumab), a biosimilar candidate to Darzalex® & Darzalex Faspro® in the U.S., and Europe
“Dr. Reddy’s has a long-standing dedication to oncology, driven by the purpose of ‘Good Health Can’t Wait’, and is committed to timely access to affordable and high-quality ...
Business Wire11mon
Dr. Reddy’s to Acquire Nicotinell and Related Portfolio in Significant Step Towards Building Global Consumer Healthcare Business
HYDERABAD, India--(BUSINESS WIRE)--Dr. Reddy’s Laboratories Ltd. (BSE ... and of our purpose of ‘Good Health Can’t Wait’. We have been steadily building our OTC presence in various ...
Your Story1y
Dr Reddy's enters trade generics business in India
Pharmaceutical major Dr Reddy's has ... quality medicines of Dr Reddy's accessible to more patients around the country in keeping with our purpose of 'Good Health Can't Wait'," said MV ...